Investigation Report on China's Tigecycline Market 2021-2025

Publisher Name :
Date: 19-Jul-2021
No. of pages: 50

Tigecycline is a broad-spectrum glycyl cyclic peptide antibiotic administered intravenously. Tigecycline is approved for complicated skin and skin structure infections or complicated intra-abdominal infections patients aged 18 and over. These infections include complicated appendicitis, burn infection, intra-abdominal abscess, deep soft tissue infection and ulcer infection. Tigecycline was developed by Wyeth Corporation of the United States and was listed in China under the trade name TYGACIL in 2011. Subsequently, some generic drugs from local Chinese companies were listed. By 2020, tigecycline has been included in China's Class B medical insurance, and there are several manufacturers in the Chinese tigecycline market.

According to CRI's market research, the sales value of tigecycline in the Chinese market increased year by year at a compound annual growth rate of 43.45% from 2016 to 2019. Due to the impact of COVID-19 on the overall diagnosis and treatment services of Chinese hospitals, the sales value of tigecycline in the Chinese market decreased to CNY 885 million in 2020 and the CAGR of tigecycline sales value from 2016 to 2020 is 28.64%.

CRI expects that the sales value of tigecycline in the Chinese market will have a restorative growth from 2016 to 2020 with the relief of COVID-19. According to the latest set of data disclosed by the World Health Organization, 700,000 people worldwide die each year due to “super bacteria” infection, and 230,000 newborns die prematurely because of this. It can be estimated that by 2050, the number of deaths may exceed 10 million. Therefore, the sales value and sales volume of tigecycline against "super bacteria" such as methicillin-resistant Staphylococcus aureus (MRSA) will continue to rise. By the first half of 2021, the new indication for tigecycline in the Chinese market-community and hospital-acquired pneumonia is under review. It can be expected that with the increase in new indications in the future, the sales value and sales volume of tigecycline have room to rise.

 

Topics Covered:

  • The impact of COVID-19 on China's Tigecycline market
  • Sales value of China's Tigecycline 2016-2020
  • Competitive landscape of China's Tigecycline market
  • Prices of Tigecycline in China
  • Prices of Tigecycline in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Tigecycline market
  • Prospect of China's Tigecycline market from 2021 to 2025

Investigation Report on China's Tigecycline Market 2021-2025

Table of Contents

1 Relevant Concepts of Tigecycline     


  • 1.1 Indications for Tigecycline     

  • 1.2 Development of Tigecycline in China    

  • 1.3 Governmental Approval of Tigecycline in China

  • 1.4 The Impact of COVID-19 on Tigecycline sales in China


 


2 Sales of Tigecycline in China, 2016-2020 


  • 2.1 Sales Value of Tigecycline     

  • 2.1.1 Overall Sales Value

  • 2.1.2 Sales Value by Region 

  • 2.2 Sales Volume of Tigecycline  

  • 2.2.1 Overall Sales Volume  

  • 2.2.2 Sales Volume by Region     

  • 2.3 Sales of Tigecycline by Dosage Form in China, 2016-2020  

  • 2.3.1 Injection

  • 2.3.2 Analysis of Other Dosage Forms


      


3 Analysis of Major Tigecycline Manufacturers in China, 2016-2020


  • 3.1 Analysis of Market Share of Major Tigecycline Manufacturers    

  • 3.1.1 Investigation on Market Share by Sales Value    

  • 3.1.2 Investigation on Market Share by Sales volume 

  • 3.2 Pfizer Ltd

  • 3.2.1 Enterprise Profile 

  • 3.2.2 Sales of TYGACIL (Pfizer Ltd’s Tigecycline) in China     

  • 3.3  Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

  • 3.3.1 Enterprise Profile 

  • 3.3.2 Sales of Zhetan (Jiangsu Hansoh Pharmaceutical Group Co., Ltd.’s Tigecycline) in China

  • 3.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

  • 3.4.1 Enterprise Profile 

  • 3.4.2 Sales of Tianjie (Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ’s Tigecycline) in China

  • 3.5 Zhejiang Hisun Pharmaceutical Co., Ltd.

  • 3.5.1 Enterprise Profile 

  • 3.5.2 Sales of Hisun Liliang (Zhejiang Hisun Pharmaceutical Co., Ltd.’s Tigecycline) in China

  • 3.6 Jiangsu Osaikang Pharmaceutical Co., Ltd.

  • 3.6.1 Enterprise Profile 

  • 3.6.2 Sales of Aotijia (Jiangsu Osaikang Pharmaceutical Co., Ltd. ’s Tigecycline) in China


 


4 Prices of Tigecycline for Different Manufacturers in China, 2020-2021


  • 4.1 Pfizer Ltd (TYGACIL)

  • 4.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (Zhetan)

  • 4.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Tianjie)

  • 4.4 Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun Liliang)

  • 4.5 Jiangsu Osaikang Pharmaceutical Co., Ltd.  (Aotijia)


 


5 Prospect of Chinese Tigecycline drug Market, 2021-2025


  • 5.1 Influential Factors of Chinese Tigecycline Market Development

  • 5.1.1 The Impact of COVID-19 on Chinese Tigecycline Market

  • 5.1.2 Market Drivers and Opportunities

  • 5.1.3 Market Threats and Challenges

  • 5.2 Forecast on Market Size 

  • 5.3 Forecast on Market Trend


 


List of Charts


  • Chart Patent Information About Tigecycline Injection Registration in China

  • Chart Sales Value of Tigecycline Injection over the World  

  • Chart Sales Value of Tigecycline Injection in China, 2016-2020 

  • Chart Sales Value of Tigecycline Injection in China by Region, 2016-2020

  • Chart Sales Volume of Tigecycline Injection in China, 2016-2020     

  • Chart Sales Volume of Tigecycline Injection in China by Region, 2016-2020

  • Chart Market Share by Sales Value of Top Tigecycline Manufacturers in China, 2016-2020

  • Chart Sales Value and Volume of TYGACIL in China, 2016-2020    

  • Chart Sales Value and Volume of Zhetan in China, 2016-2020

  • Chart Sales Value and Volume of Tianjie in China, 2016-2020   

  • Chart Sales Value and Volume of Hisun Liliang in China, 2016-2020

  • Chart Sales Value and Volume of Aotijia in China, 2016-2020          

  • Chart Referential Prices of TYGACIL in China, 2020-2021

  • Chart Referential Prices of Zhetan in China, 2020-2021      

  • Chart Referential Prices of Tianjie in China, 2020-2021            

  • Chart Referential Prices of Hisun Liliang in China, 2020-2021    

  • Chart Referential Prices of Aotijia in China, 2020-2021

  • Chart Forecast on Sales Value of Tigecycline in China, 2021-2025

  • Chart Forecast on Sales Volume of Tigecycline in China, 2021-2025

  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs